SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-14 |
| Reported value | $931,121,604 |
| Positions | 2 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| Cava Group Inc | CAVA | COM | $510,747,055 | 6,507,990 |
| Lexicon Pharmaceuticals Inc | LXRX | COM NEW | $420,374,549 | 175,156,062 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.